CRISPR-Cas9, the widely hailed genome-editing tool is under scrutiny, not for the possible ethical ramifications of CRISPR being employed as a human genome alteration tool, but rather for who should own the foundational and lucrative patent rights: the University of...
An update on the Cancer Moonshot Initiative and more at the 11th PMWC 2017 Silicon Valley with 250+ speakers and 50+ sessions While its creation was only announced earlier this year, with Vice President Joe Biden at the helm instilling hope and calling for action, the...
Q: Precision medicine will have a huge economic impact on health care. As a result, value-based versus cost-based pricing needs to be considered from a patient, pharma, and payor perspective. What are some of the challenges of implementing value-based pricing, and how...
Q: You helped make one of the most monumental discoveries in biology that allows to alter an organism's DNA. Can you tell us how this came about? What lead to the discovery? A: CRISPR-Cas9 gene editing technology is the result of a fundamental, curiosity-driven...
Q: Immunotherapy has rapidly evolved into a game-changing cancer treatment strategy for a wide array of different cancers, though some patients respond better than others.How important are biomarker assays for patient-selection to guide clinicians to use...
Ever since the first human genome was sequenced, the expectation has been that biobanking would be one of the critical cornerstones that enables the revolution in the practice of medicine–precision medicine. Biobanks provide critical research and infrastructure...
PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.
View the top 3 talks from PMWC here (password: top-videos).
